**Core Concept**
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder characterized by uncontrolled proliferation of myeloid cells. The pathogenesis of CML involves a specific chromosomal translocation that leads to the formation of a fusion gene.

**Why the Correct Answer is Right**
The chromosomal translocation associated with CML is t(9;22)(q34;q11), also known as the Philadelphia chromosome. This translocation results in the fusion of the BCR (breakpoint cluster region) gene on chromosome 22 with the ABL1 gene on chromosome 9, forming the BCR-ABL1 fusion gene. The BCR-ABL1 fusion protein has constitutive tyrosine kinase activity, which leads to the activation of downstream signaling pathways that promote cell proliferation and survival.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because t(8;14)(q24;q32) is associated with Burkitt lymphoma, a different type of hematological malignancy.
* **Option B:** This option is incorrect because t(11;14)(q13;q32) is associated with mantle cell lymphoma, another type of lymphoma.
* **Option C:** This option is incorrect because t(15;17)(q22;q21) is associated with acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML).

**Clinical Pearl / High-Yield Fact**
The BCR-ABL1 fusion gene is a specific and sensitive marker for CML, and its detection is essential for the diagnosis of this disease. The development of tyrosine kinase inhibitors (TKIs) targeting the BCR-ABL1 fusion protein has revolutionized the treatment of CML.

**Correct Answer: C. t(9;22)(q34;q11)**